PMC:7601109 / 690-886 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T6","span":{"begin":10,"end":20},"obj":"Disease"}],"attributes":[{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0006516"}],"text":"f eating. Sarcopenia has multiple detrimental effects including falls, hospitalization, disability, and institutionalization. Although a few pharmacological agents (e.g., bimagrumab, sarconeos, an"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T96306","span":{"begin":21,"end":24},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T81360","span":{"begin":135,"end":136},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"f eating. Sarcopenia has multiple detrimental effects including falls, hospitalization, disability, and institutionalization. Although a few pharmacological agents (e.g., bimagrumab, sarconeos, an"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T39259","span":{"begin":2,"end":8},"obj":"http://purl.obolibrary.org/obo/GO_0007631"}],"text":"f eating. Sarcopenia has multiple detrimental effects including falls, hospitalization, disability, and institutionalization. Although a few pharmacological agents (e.g., bimagrumab, sarconeos, an"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":64,"end":69},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0002527"}],"text":"f eating. Sarcopenia has multiple detrimental effects including falls, hospitalization, disability, and institutionalization. Although a few pharmacological agents (e.g., bimagrumab, sarconeos, an"}

{"project":"LitCovid-sentences","denotations":[{"id":"T7","span":{"begin":10,"end":125},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"f eating. Sarcopenia has multiple detrimental effects including falls, hospitalization, disability, and institutionalization. Although a few pharmacological agents (e.g., bimagrumab, sarconeos, an"}

{"project":"LitCovid-PubTator","denotations":[{"id":"34","span":{"begin":171,"end":181},"obj":"Chemical"},{"id":"43","span":{"begin":10,"end":20},"obj":"Disease"}],"attributes":[{"id":"A34","pred":"tao:has_database_id","subj":"34","obj":"MESH:C000596367"},{"id":"A43","pred":"tao:has_database_id","subj":"43","obj":"MESH:D055948"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"f eating. Sarcopenia has multiple detrimental effects including falls, hospitalization, disability, and institutionalization. Although a few pharmacological agents (e.g., bimagrumab, sarconeos, an"}